Position in NTRA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$675,166
+$65,558 QoQ
Shares Held
3,376
+26.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.740521327014218.ToString("F0")%
Shared 0.ToString("F0")%
None 99.25947867298578.ToString("F0")%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026NewEdge Wealth, LLC holds $41,573,748 across 8 Diagnostics & Research names. NTRA ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
49,777 | $23,902,417 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
15,836 | $7,783,869 | |
| 3 | DHR |
Danaher Corp /De/
|
23,038 | $4,368,004 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
5,731 | $3,220,191 | |
| 5 | ICLR |
Icon PLC
|
8,038 | $889,485 | |
| 6 | NTRA |
Natera, Inc.
This page
|
3,376 | $675,166 | |
| 7 | A |
Agilent Technologies, Inc.
|
4,674 | $532,742 | |
| 8 | RDNT |
RadNet, Inc.
|
3,612 | $201,874 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $675,166 | 3,376 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $609,608 | 2,661 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $372,323 | 2,313 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||